Is atherosclerosis regression a realistic goal of statin therapy and what does that mean?

Area of Science:

• Cardiovascular Medicine
• Pharmacology
• Medical Imaging

Background:

• Atherosclerosis involves abnormal lipoprotein metabolism and leukocyte infiltration, leading to cardiovascular diseases.
• Statins are proven effective in reducing cardiovascular disease risk through primary and secondary prevention.
• Statins demonstrate consistent antiatherosclerotic effects, slowing progression and inducing regression.

Purpose of the Study:

• To review the evidence for imaging modalities in detecting atherosclerotic plaque regression.
• To discuss the effects of statins on the atherosclerotic process.
• To evaluate the clinical relevance of atherosclerosis regression.

Main Methods:

• Review of scientific literature on statin therapy and atherosclerosis.
• Analysis of technological advances in imaging for atherosclerosis assessment.
• Discussion of current limitations in using plaque progression as a therapeutic goal.

Main Results:

• Statins are the only agents consistently shown to slow atherosclerosis progression and induce regression.
• Advanced imaging allows direct visualization and assessment of atherosclerotic plaques and plaque burden.
• Despite imaging advances, atherosclerotic plaque progression is not currently a therapeutic target.

Conclusions:

• Statins play a crucial role in managing atherosclerosis by slowing progression and promoting regression.
• Imaging modalities are vital for evaluating the impact of therapies like statins on atherosclerotic plaques.
• Further research is needed to overcome limitations and establish plaque progression as a therapeutic goal.